1.Using distance comparison method to build pharmacophore model of epidermal growth factor receptor inhibitors.
Yan-shen GUO ; Feng-ming CHU ; Zong-ru GUO
Acta Academiae Medicinae Sinicae 2004;26(4):379-384
OBJECTIVETo build 3D-pharmacophore model of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors using distance comparisons method and design novel EGFR inhibitors.
METHODSThirteen typical EGFR inhibitors were selected, and their biologically active conformations were obtained by using DOCK5.0 program, then 3D-pharmacophore model of EGFR inhibitors was built using distance comparisons method.
RESULTSValidation of the 3D-pharmacophore model was carried out and novel structures with potential inhibitory activity were selected by means of 3D-searching and docking method.
CONCLUSIONThis method can improve hit rate of lead compounds discovery and can be used to design novel EGFR inhibitors.
Drug Design ; Enzyme Inhibitors ; Epidermal Growth Factor ; metabolism ; Models, Chemical ; Protein-Tyrosine Kinases ; antagonists & inhibitors ; chemistry ; pharmacology ; Receptor, Epidermal Growth Factor ; antagonists & inhibitors ; chemistry ; Structure-Activity Relationship
2.Effects of Platelet Lysate Preparations on the Proliferation of HaCaT Cells.
Sae Yun BAIK ; Young Ae LIM ; Seon Joo KANG ; Sun Hyun AHN ; Wee Gyo LEE ; Chul Ho KIM
Annals of Laboratory Medicine 2014;34(1):43-50
BACKGROUND: Standard protocols are lacking for the preparation of platelet lysates (PL) as an alternative to using fetal bovine serum as a cell culture supplement. This study aimed to establish optimum conditions for preparing PL for use in cell cultures. METHODS: Cell density in three pooled platelet concentrates (PC) were adjusted to 1x10(12)/L and 2x10(12)/L. PL was prepared from PC by 1 to 3 freeze-thaw (FT) cycles. HaCaT cells were cultured in media supplemented with 5% or 10% PL. Cell numbers were estimated using a Cell Counting Kit-8 (CCK-8; Dojindo Laboratories, Japan). Growth factors were quantified by using the Luminex 200 system (Luminex Corporation, USA). RESULTS: Cell proliferation rates in the presence of PLs were similar when prepared from PCs of both cell densities. The rates were higher in media containing 5% PL than 10% PL when prepared by two FT cycles. Concentrations of vascular endothelial growth factor (VEGF), platelet-derived growth factor-AB/BB (PDGF-AB/BB), PDGF-AA, and epidermal growth factor (EGF) were significantly higher in PL prepared from PC with a cell density of 2x10(12)/L than 1x10(12)/L PC. However, only VEGF and PDGF-AA concentrations in PLs were correlated with HaCaT cell counts. CONCLUSIONS: The 5% PL from PC with a cell density of 1x10(12)/L prepared by two FT cycles treatment was the most effective condition that supported steady HaCaT cell proliferation. Our finding may be useful for preparing PL-supplemented cell culture media.
Blood Platelets/chemistry/*metabolism
;
Cell Line
;
Cell Proliferation/drug effects
;
Culture Media/pharmacology
;
Epidermal Growth Factor/chemistry/pharmacology
;
Humans
;
Platelet-Derived Growth Factor/chemistry/pharmacology
;
Vascular Endothelial Growth Factor A/chemistry/pharmacology
3.The action of decorin in anti-fibrosis and anti-cancer.
Weifeng MA ; Yi TAN ; Shaohui CAI ; Hongyuan CHEN ; Jun DU ; Shaoxi CAI
Journal of Biomedical Engineering 2007;24(1):222-225
Decorin (DCN) is a member of the small leucine-rich proteoglycan gene family. Many studies indicated that DCN inhibited fibrosis and scar-formation by neutralization of TGF-P and interfering the binding of TGF-beta with its receptor, which induced ectopic deposition of extracellular matrix. Additionally, DCN can prevent the proliferation and metastasis of tumor cells by activating EGFR/MAPK/p21 signal pathway and inhibiting the cell proliferation pathway mediated by EGF-EGFR. It is suggested that the recombinant DCN had potential pharmaceutical potency in treatment of chronic fibrosis and neoplasm for its critical biological activities and low immunogenicity.
Animals
;
Antineoplastic Agents
;
pharmacology
;
Decorin
;
Extracellular Matrix Proteins
;
chemistry
;
pharmacology
;
Fibrosis
;
prevention & control
;
Humans
;
Proteoglycans
;
chemistry
;
pharmacology
;
Receptor, Epidermal Growth Factor
;
antagonists & inhibitors
;
Recombinant Proteins
;
pharmacology
;
Transforming Growth Factor beta1
;
antagonists & inhibitors
4.Rapid differentiation of human umbilical cord-derived mesenchymal stem cells into insulin-secreting cells under the sole induction of biological products.
Yue-Chun WANG ; Yuan ZHANG ; A-Lin DUAN ; Wei-Xia LIN ; Qiao-Dan ZHENG ; Wen-Lu XU
Acta Physiologica Sinica 2010;62(1):73-78
In order to explore the feasibility of inducing the human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) to differentiate into insulin-secreting cells with biological products alone, hUC-MSCs were separated and purified from the whole umbilical cord by the sequent digestion of collagenase II and trypsin followed by two-step centrifugation. hUC-MSCs were induced with IMDM culture medium containing epidermal growth factor (EGF), basic fibroblast growth factor (bFGF) and Ginkgo biloba extract (GBE). Before and after the induction, the morphological changes were observed under inverse microscope; the islet-related genes were detected by RT-PCR; islet-like clusters (ILCs) were identified by dithizone (DTZ) staining; PDX-1 and immunoreactive insulin (IRI) were examined by immunofluorescence method; the quantity and quality of IRI secretion were assayed by chemiluminescence immunoassay and Western blot respectively. The results showed that the purified hUC-MSCs presented long spindle-like shape and parallel or spiral arrangement which are typical morphological features of MSCs. After the induction, hUC-MSCs changed gradually into round or oval shape and gathered together to form ILCs; there were more than one hundred clusters on the growth surface of a flask of T25; ILCs were stained into positive mauve by DTZ and positive for PDX-1 and IRI; Western blot displayed that most of the IRI was proinsulin (PI). Therefore, hUC-MSCs can rapidly differentiate into insulin-secreting cells under the sole induction of EGF, bFGF, GBE and IMDM, but ILCs are not mature enough to produce sufficient true insulin.
Cell Differentiation
;
Cells, Cultured
;
Epidermal Growth Factor
;
pharmacology
;
Fibroblast Growth Factor 2
;
pharmacology
;
Ginkgo biloba
;
chemistry
;
Humans
;
Insulin-Secreting Cells
;
cytology
;
Mesenchymal Stromal Cells
;
cytology
;
Plant Extracts
;
pharmacology
;
Umbilical Cord
;
cytology
5.Effect of Pongamia pinnata root flavonoids on the quality of ulcer healing and expression of EGF and TGF-alpha in the rat model of gastric ulcer induced by acetic acid.
Ke-Yun LIU ; Yi ZHU ; Xian-Zhen HUANG
Chinese Journal of Applied Physiology 2012;28(5):435-438
OBJECTIVETo observe the effects and mechanisms of Pongamia pinnata root flavonoids (PRF) on the experimental gastric ulcer induced by acetic acid and to study the mechanism of PRF on the quality of ulcer healing.
METHODSThe models were established by acetic acid erosion, the quality of ulcer healing of PRF on the model of gastric ulcer were observed. The contents of epidermal growth factor (EGF) in serum were determined by radioimmunoassay. The expression of EGF and transforming growth factor-alpha (TGF-alpha) were detected by immunohistochemistry (SP).
RESULTSPRF significantly inhibited ulcerative formation induced by acetic acid (P < 0.05, P < 0.01). PRF could significantly increase the EGF and TGF-alpha (P < 0.05, P < 0.01) expression of para-ulcer mucosa tissue and improve the EGF contents in blood serum (P < 0.05, P < 0.01).
CONCLUSIONPRF increases the contents of EGF in serum and the expression of EGF and TGF-alpha in the tissue around gastric ulcer which might be one of possible mechanisms that PRF improves quality of ulcer healing.
Acetic Acid ; Animals ; Epidermal Growth Factor ; blood ; Female ; Flavonoids ; pharmacology ; Gastric Mucosa ; metabolism ; Male ; Millettia ; chemistry ; Plant Roots ; chemistry ; Rats ; Rats, Sprague-Dawley ; Stomach Ulcer ; chemically induced ; drug therapy ; metabolism ; Transforming Growth Factor alpha ; metabolism
6.Effect of beta-mercaptoethanol or epidermal growth factor supplementation on in vitro maturation of canine oocytes collected from dogs with different stages of the estrus cycle.
Min Kyu KIM ; Yuda Heru FIBRIANTO ; Hyun Ju OH ; Goo JANG ; Hye Jin KIM ; Kyu Seung LEE ; Sung Keun KANG ; Byeong Chun LEE ; Woo Suk HWANG
Journal of Veterinary Science 2004;5(3):253-258
Supplementation of beta-mercaptoethanol (beta-ME) in in vitro maturation (IVM) medium was shown to improve embryo development and quality in several species. Epidermal growth factor (EGF) was also shown to improve IVM of human oocyte and embryo development after in vitro fertilization (IVF). The effect of these two compounds were suggested to be mediated through the synthesis of glutathione (GSH) which is known to play an important role in protecting the cell or embryos from oxidative damage. Thus, it is suggested that supplementation of canine IVM medium with beta-ME or EGF may be of benefit due to its positive role in IVM of various mammalian oocytes and embryo development, including cattle, pigs, rodents and humans. This study investigates the effect of ovarian estrus stage on canine oocyte quality and supplementation of medium with beta-ME or EGF on IVM of canine oocytes. As results, a significantly higher percentage of oocytes progressed to metaphase II (MII) stage in 50 or 100 microM of beta-ME supplemented oocytes collected from the follicular stage. The maturation rate to metaphase I (MI) stage was also significantly higher in oocytes collected from follicular stage and cultured with 25 or 100 microM compared to other experimental groups. After IVM culture, oocytes recovered from dogs with the follicular stage and matured in TCM-199 supplemented with 20 ng/ml EGF yielded better oocyte maturation to MII phase compared to other groups. Taken together, supplementation of beta-ME (50 or 100 microM) or EGF (20 ng/ml) improved IVM of canine oocytes to MII stage.
Animals
;
Benzimidazoles/chemistry
;
Dogs/*physiology
;
Epidermal Growth Factor/*pharmacology
;
Estrus/*physiology
;
Female
;
Fluorescent Dyes/chemistry
;
Meiosis/drug effects/physiology
;
Mercaptoethanol/*pharmacology
;
Microscopy, Ultraviolet/veterinary
;
Oocytes/drug effects/growth&development/*physiology
;
Ovary/drug effects/*physiology
7.Study on the differentiation of human mesenchymal stem cells into vascular endothelial-like cells.
Rong XU ; Jinyong XU ; Wei LIU
Journal of Biomedical Engineering 2014;31(2):389-393
To explore the feasibility of mesenchymal stem cells (MSCs) acting as seed cells in tissue engineering, we isolated human bone marrow MSCs and differentiated them into vascular endothelial-like cells (ELCs) in vitro. Bone marrow mononuclear cells (BMSCs) were isolated by the method of percoll density centrifugation, and seeded in Dulbecco Modified Eagle Medium supplemented with 10% fetal bovine serum. MSCs were purified through multiple adherent cultures, and differentiated into ELCs induced by endothelial cell growth medium-2 (EBM-2) medium containing vascular endothelial growth factor (VEGF), human fibroblast growth factor (hFGF), insulin like growth factors 1 (IGF-1), and human epidermal growth factor (hEGF). The relative biologic characteristics of ELCs including cell morphology and phenotype were studied by inverted microscope and flow cytometry. The induced cells were identified by immunofluorescence with CD31 and Von Willebrand factor (vWF). The results showed that the morphology of MSCs was long-spindle and vortex-like growth. After induction of differentiation, the cells were round, and similar to vascular endothelial cells (ECs). Flow cytometric analysis revealed that ELCs expressed ECs specific surface markers of CD31 and vascular endothelial cadherin (VE-cadherin), but not CD133. Immunofluorescence results also confirmed that ELCs expressed CD31 and vWF. The results suggested that ELCs possed similar cell biological characteristics with ECs. In one word, human MSCs derived from bone marrow have the potential to differentiate into ECs in vitro, and show clinical feasibility acting as ideal donor cells of vascular tissue engineering.
Antigens, CD
;
metabolism
;
Bone Marrow Cells
;
Cadherins
;
metabolism
;
Cell Culture Techniques
;
Cell Differentiation
;
Cells, Cultured
;
Culture Media
;
chemistry
;
Endothelial Cells
;
cytology
;
Epidermal Growth Factor
;
pharmacology
;
Fibroblast Growth Factors
;
pharmacology
;
Flow Cytometry
;
Humans
;
Insulin-Like Growth Factor I
;
pharmacology
;
Mesenchymal Stromal Cells
;
cytology
;
Platelet Endothelial Cell Adhesion Molecule-1
;
metabolism
;
Tissue Engineering
;
Vascular Endothelial Growth Factor A
;
pharmacology
;
von Willebrand Factor
;
metabolism
8.1-Methoxycarbony-β-carboline from Picrasma quassioides exerts anti-angiogenic properties in HUVECs in vitro and zebrafish embryos in vivo.
Qing-Hua LIN ; Wei QU ; Jian XU ; Feng FENG ; Ming-Fang HE
Chinese Journal of Natural Medicines (English Ed.) 2018;16(8):599-609
Angiogenesis is a crucial process in the development of inflammatory diseases, including cancer, psoriasis and rheumatoid arthritis. Recently, several alkaloids from Picrasma quassioides had been screened for angiogenic activity in the zebrafish model, and the results indicated that 1-methoxycarbony-β-carboline (MCC) could effectively inhibit blood vessel formation. In this study, we further confirmed that MCC can inhibit, in a concentration-dependent manner, the viability, migration, invasion, and tube formation of human umbilical vein endothelial cells (HUVECs) in vitro, as well as the regenerative vascular outgrowth of zebrafish caudal fin in vivo. In the zebrafish xenograft assay, MCC inhibited the growth of tumor masses and the metastatic transplanted DU145 tumor cells. The proteome profile array of the MCC-treated HUVECs showed that MCC could down-regulate several angiogenesis-related self-secreted proteins, including ANG, EGF, bFGF, GRO, IGF-1, PLG and MMP-1. In addition, the expression of two key membrane receptor proteins in angiogenesis, TIE-2 and uPAR, were also down-regulated after MCC treatment. Taken together, these results shed light on the potential therapeutic application of MCC as a potent natural angiogenesis inhibitor via multiple molecular targets.
Angiogenesis Inhibitors
;
chemistry
;
pharmacology
;
Animals
;
Carbolines
;
chemistry
;
pharmacology
;
Cell Movement
;
drug effects
;
Cell Proliferation
;
drug effects
;
Epidermal Growth Factor
;
genetics
;
metabolism
;
Fibroblast Growth Factors
;
genetics
;
metabolism
;
Human Umbilical Vein Endothelial Cells
;
cytology
;
drug effects
;
metabolism
;
Humans
;
Insulin-Like Growth Factor I
;
genetics
;
metabolism
;
Neovascularization, Physiologic
;
drug effects
;
Picrasma
;
chemistry
;
Plant Extracts
;
chemistry
;
pharmacology
;
Receptor, TIE-2
;
genetics
;
metabolism
;
Zebrafish
;
embryology
9.Effect of TSPG on proliferation and differentiation of human embryonic neural stem cell into dopaminergic neuron.
Sha-li WANG ; Ying-bo LI ; Ya-ping WANG ; Min FENG
China Journal of Chinese Materia Medica 2007;32(13):1310-1313
OBJECTIVETo investigate the effects of total saponins of panax ginseng (TSPG) on proliferation and differentiation of human embryonic neural stem cell (NSC) into dopaminergic neuron.
METHODIsolation, cultivation and identification of human embryonic NSC from cerebral cortex of 7-12 week abortus. By using flow cytometry and MTT assay, the effects of various concentration of TSPG and TSPG cooperating with cytokines( EGF, bFGF) in NSC culture media for 3 days on proliferation of human embryonic NSC has studied. By employing immunocytochemistry assay of the expression of tyrosine hydroxylase (TH), the effect of different dilution of TSPG and TSPG cooperating with IL-1 on induced differentiation of human embryonic NSC into dopaminergic neuron has researched.
RESULTTSPG can significantly promote the proliferation of NSC. When TSPG cooperating with EGF and bFGF, the proliferation of NSC is much stronger than that of only using FGF and bFGF. TSPG also induces NSC to differentiate into dopaminergic neuron, especially when TSPG is cooperating with IL-1.
CONCLUSIONTSPG can not only obviously accelerate the proliferation of NSC, but also significantly induce differentiation of NSC into dopaminergic neuron.
Cell Differentiation ; drug effects ; Cell Proliferation ; drug effects ; Cells, Cultured ; Dopamine ; metabolism ; Drug Synergism ; Embryonic Stem Cells ; cytology ; drug effects ; metabolism ; Epidermal Growth Factor ; pharmacology ; Fibroblast Growth Factor 2 ; pharmacology ; Humans ; Immunohistochemistry ; Interleukin-1 ; pharmacology ; Neurons ; cytology ; drug effects ; metabolism ; Panax ; chemistry ; Plants, Medicinal ; chemistry ; Saponins ; isolation & purification ; pharmacology ; Tyrosine 3-Monooxygenase ; metabolism
10.Phosphorylation of glycogen synthase kinase-3beta at serine-9 by phospholipase Cgamma1 through protein kinase C in rat 3Y1 fibroblasts.
Soon Young SHIN ; Se Chang YOON ; Young Ho KIM ; Yong Sik KIM ; Young Han LEE
Experimental & Molecular Medicine 2002;34(6):444-450
Phospholipase Cgamma1 (PLCgamma1) plays an important role in controlling cellular proliferation and differentiation. PLCgamma1 is overexpressed in some tumors, and its overexpression induces solid tumors in nude mice. However, the regulatory mechanisms underlying PLCgamma1-induced cell proliferation are not fully understood. Here we show that overexpression of PLCgamma1 highly phosphorylated glycogen synthase kinase-3beta (GSK-3beta) at serine-9 in 3Y1 fibroblasts. Inhibition of protein kinase C (PKC)s with GF109203X abrogated GSK-3beta phosphorylation by PLCgamma1. We also found that steady-state level of cyclin D1 protein, but not cyclin D1 mRNA, was highly elevated in response to serum stimulation in PLCgamma1-transfected cells as compared with vector-transfected cells. Since GSK-3beta is involved in cyclin D1 proteolysis in response to mitogenic stimulation, PLCgamma1-mediated GSK-3beta phosphorylation may function as a regulation of cyclin D1 accumulation in PLCgamma1-overexpressing cells.
Animals
;
Cyclin D1/metabolism
;
Epidermal Growth Factor/pharmacology
;
Fibroblasts
;
Gene Expression
;
Glycogen Synthase Kinase 3/chemistry/*metabolism
;
Mitogens/pharmacology
;
Phospholipase C/genetics/*metabolism
;
Phosphorylation/drug effects
;
Phosphoserine/*metabolism
;
Protein Kinase C/antagonists & inhibitors/*metabolism
;
Rats
;
Signal Transduction